Announced Mon, 6 Jul · 15:45 IST
Compliance Certificate under Reg 74(5) for Q1 FY27
Compliance View source PDF
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.8%1-day move
₹237.90
prior close
₹235.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.6-0.8-1.1-3.8-2.6-2.1-3.5-5.3-5.2————
Up moveDown movePending
AI summary
Routine quarterly compliance filing. The company's Registrar and Share Transfer Agent, MCS Share Transfer Agent Limited, has submitted a certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. It confirms that share certificates received for dematerialization during the quarter were properly listed on the exchanges and cancelled, with the depository recorded as the registered owner. This is a standard SEBI requirement fulfilled every quarter.
Likely market impact
No impact on shareholders or stock price. This is a routine procedural compliance filing with no material information.